NEXTCURE INC
NXTC·65343E207·US·Common Stock·Healthcare - Biotechnology-Activist
NXTC (NEXTCURE INC) is held by 11 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($646,503), GEODE CAPITAL MANAGEMENT, LLC ($327,136), BlackRock, Inc. ($296,830). Net institutional sentiment: Mixed.
11
Holders
Avg rating(3 Elite)
$1.8M
Total Value
63% (14)
Fund Consensus
5 buying - 3 selling
Who's Trading
ActivistSISilverArc Capital Management, LLC4.9%May 13, 2026
ActivistSZSimcere Zaiming, Inc.9.4%May 6, 2026
ActivistSVSofinnova Venture Partners IX, L.P. ("SVP IX")7.1%Mar 5, 2026
ActivistIKIkarian Capital, LLC10.0%Feb 17, 2026
ActivistSMSquadron Master Fund LP9.9%Feb 17, 2026
ActivistP(Pfizer Inc. (IRS Identification No.: 13-5315170)3.0%Feb 13, 2026
ActivistSISilverArc Capital Management, LLC5.0%Feb 12, 2026
ActivistAAAffinity Asset Advisors, LLC10.0%Jan 29, 2026
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer